Has Rustin Ajdari, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $15,153 in general payments to Rustin Ajdari, DPM across 155 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rustin Ajdari, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rustin Ajdari, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rustin Ajdari, DPM

Podiatrist · Slidell, LANPI 1447827951

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by ALON Medical Technology at 27.3% of the total. Reporting peaked in 2024 at $7,944 and has fallen 71.3% since, to $2,280 in 2025. Among podiatrist clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,153in general payments, 2019–2025

Across 155 payments — averaging $97.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ALON Medical Technology$4K
Stryker$3K
Medline Industries LP$1K
Orthofix Medical, Inc.$1K
Acumed LLC$1K
Arthrex$600
plus $3K from 15 others

What the payments were for

Travel & lodging$5,98540%
Food & beverage$5,56737%
Education$3,60024%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ALON Medical Technology	9	$4,133
Stryker	70	$3,458
Medline Industries LP	8	$1,447
Orthofix Medical, Inc.	13	$1,236
Acumed LLC	5	$1,233
Arthrex	7	$600
Vilex LLC	1	$589
Sanara Medtech Inc.	7	$323
Zimmer Biomet	8	$301
Smith+Nephew	5	$248
Integra Lifesciences Corporation	2	$238
Johnson & Johnson	5	$236
Treace Medical Concepts, Inc.	5	$208
Paragon 28, Inc.	1	$173
Organogenesis Inc.	3	$161
Baxter Healthcare	1	$143
Bone Support Inc.	1	$143
Averitas Pharma Inc.	1	$125
Flower Orthopedics Coporation	1	$99
Kerecis Limited	1	$42
Boston Scientific	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACUMED$1,602
OsteoMed$1,602
TrueLok$898
INTEGRA$715
ORTHOLOC 3DI$607
ORTHOLOC 2 LAPIFUSE$603
REDEMPTION$589
INTEGRA DERMAL REGENERATION TEMPLATE$238
PRIMATRIX$238
Portfolio$173
CERAMENTBONE VOID FILLER$143
CERAMENT G$143
TAPESTRY$142
ALLOGRAFT BIO-IMPLANTS$136
Qutenza$125
AUGMENT INJECTABLE$119
INFINITY ADAPTIS$118
Lapiplasty System$117
GRAFTJACKET$106
STRAVIX PL$100

How this compares

$15,153 in reported general payments places this provider in the 95th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana →

Medicare billing

Part B allowed, 2024

$18,859

Medicare patients

Services billed

193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciclopirox	13	$345
Fluconazole	19	$226
Doxycycline Hyclate	12	$182
Methylprednisolone	26	$176
Gabapentin	15	$102
Meloxicam	28	$62

Paid to pharmacies, not to this prescriber.